dc.contributor.author |
Hoteit R. |
dc.contributor.author |
Halas H. |
dc.contributor.author |
Hassanieh S. |
dc.contributor.author |
Mahfouz R.A.R. |
dc.contributor.editor |
|
dc.date |
May-2012 |
dc.date.accessioned |
2017-10-05T15:59:34Z |
dc.date.available |
2017-10-05T15:59:34Z |
dc.date.issued |
2012 |
dc.identifier |
10.1089/gtmb.2011.0220 |
dc.identifier.isbn |
|
dc.identifier.issn |
19450265 |
dc.identifier.uri |
http://hdl.handle.net/10938/19083 |
dc.description.abstract |
Aims: The rate of laboratory referrals for thrombophilia patients' genetic workup was assessed and compared among the medical and surgical specialties and subspecialties at a major tertiary care center in Lebanon. Methods: DNA extraction was performed using the PEL-FREEZ extraction kit (PEL-FREEZ; DYNAL) and the Factor V, prothrombin, and methylenetetrahydrofolate reductase genotypic profiles were done using the FV-PTH-MTHFR StripAssay kit (ViennaLab) that employs a polymerase chain reaction-reverse hybridization method. A total of 2238 referred cases were analyzed. Results: Around 42.23percent of all referred cases turned out to have a thrombosis-associated mutation. Referrals from medical and surgical specialties were almost equal. In the surgical specialty, most referrals came from the department of Obstetrics and Gynecology, while in the medical speciality, most of the workup referrals originated from the Hematology-Oncology physicians. However, low referral rates were reported from the emergency department and family medicine practitioners. Conclusion: Genetic testing for thrombophilia workup is gaining more importance among the different medical and surgical specialties and is worth being introduced into the offered test lists of all established molecular diagnostics laboratories. © 2012 Mary Ann Liebert, Inc. |
dc.format.extent |
|
dc.format.extent |
Pages: (459-462) |
dc.language |
English |
dc.publisher |
NEW ROCHELLE |
dc.relation.ispartof |
Publication Name: Genetic Testing and Molecular Biomarkers; Publication Year: 2012; Volume: 16; no. 5; Pages: (459-462); |
dc.relation.ispartofseries |
|
dc.relation.uri |
|
dc.source |
Scopus |
dc.subject.other |
|
dc.title |
Laboratory referral rates of genetic tests for thrombophilia workup in a major referral center |
dc.type |
Article |
dc.contributor.affiliation |
Hoteit, R., Department of Pathology, American University, Beirut Medical Center, Riad El Solh 1107 2020, Beirut 11-0236, Lebanon |
dc.contributor.affiliation |
Halas, H., Department of Pathology, American University, Beirut Medical Center, Riad El Solh 1107 2020, Beirut 11-0236, Lebanon |
dc.contributor.affiliation |
Hassanieh, S., Department of Pathology, American University, Beirut Medical Center, Riad El Solh 1107 2020, Beirut 11-0236, Lebanon |
dc.contributor.affiliation |
Mahfouz, R.A.R., Department of Pathology, American University, Beirut Medical Center, Riad El Solh 1107 2020, Beirut 11-0236, Lebanon |
dc.contributor.authorAddress |
Mahfouz, R.A.R.; Department of Pathology, American University, Beirut Medical Center, Riad El Solh 1107 2020, Beirut 11-0236, Lebanon; email: rm11@aub.edu.lb |
dc.contributor.authorCorporate |
University: American University of Beirut Medical Center; Faculty: Faculty of Medicine; Department: Pathology and Laboratory Medicine; |
dc.contributor.authorDepartment |
Pathology and Laboratory Medicine |
dc.contributor.authorDivision |
|
dc.contributor.authorEmail |
rm11@aub.edu.lb |
dc.contributor.faculty |
Faculty of Medicine |
dc.contributor.authorInitials |
Hoteit, R |
dc.contributor.authorInitials |
Halas, H |
dc.contributor.authorInitials |
Hassanieh, S |
dc.contributor.authorInitials |
Mahfouz, RAR |
dc.contributor.authorOrcidID |
|
dc.contributor.authorReprintAddress |
Mahfouz, RAR (reprint author), Amer Univ Beirut, Med Ctr, Dept Pathol and Lab Med, Riad El Solh 1107 2020, Beirut 110236, Lebanon. |
dc.contributor.authorResearcherID |
|
dc.contributor.authorUniversity |
American University of Beirut Medical Center |
dc.description.cited |
Ayadurai T, 2009, J OBSTET GYNAECOL RE, V35, P1061, DOI 10.1111-j.1447-0756.2009.01067.x; Cohn DM, 2010, J THROMB HAEMOST, V8, P513, DOI 10.1111-j.1538-7836.2009.03710.x; Finan RR, 2002, AM J HEMATOL, V71, P300, DOI 10.1002-ajh.10223; Hussein AS, 2010, THROMB RES, V126, pE78, DOI 10.1016-j.thromres.2010.04.017; Isma'eel H, 2006, J THROMB THROMBOLYS, V22, P121, DOI 10.1007-s11239-006-8953-3; Isma'eel H, 2006, J THROMB THROMBOLYS, V21, P267, DOI 10.1007-s11239-006-5537-1; Jadaon MM, 2010, DIAGN MOL PATHOL, V19, P180; Kfoury E, 2009, MOL BIOL REP, V36, P1041, DOI 10.1007-s11033-008-9278-4; Kosar A, 2011, BLOOD COAGUL FIBRIN, V22, P14, DOI 10.1097-MBC.0b013e32834013f2; Larciprete G, 2010, J OBSTET GYNAECOL RE, V36, P996, DOI 10.1111-j.1447-0756.2010.01262.x; Lund M, 2010, HUM REPROD, V25, P2978, DOI 10.1093-humrep-deq280; Mazoyer E, 2009, BLOOD COAGUL FIBRIN, V20, P503, DOI 10.1097-MBC.0b013e32832f5d7a; Otrock ZK, 2008, ANN HEMATOL, V87, P1013, DOI 10.1007-s00277-008-0543-3; Rahimi Z, 2010, BLOOD COAGUL FIBRIN, V21, P385, DOI 10.1097-MBC.0b013e328330e69a; Sabbagh A, 2009, MOL BIOL REP, V36, P399, DOI 10.1007-s11033-007-9193-0; Tug E, 2011, INTERNAL MED, V50, P17, DOI 10.2169-internalmedicine.50.4144; Yokus O, 2009, INT J HEMATOL, V90, P583, DOI 10.1007-s12185-009-0447-6; Zahed LF, 2006, AM J OBSTET GYNECOL, V195, P1114, DOI 10.1016-j.ajog.2006.06.082 |
dc.description.citedCount |
1 |
dc.description.citedTotWOSCount |
1 |
dc.description.citedWOSCount |
1 |
dc.format.extentCount |
4 |
dc.identifier.articleNo |
|
dc.identifier.coden |
|
dc.identifier.pubmedID |
22191678 |
dc.identifier.scopusID |
84861524589 |
dc.identifier.url |
|
dc.publisher.address |
140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA |
dc.relation.ispartofConference |
|
dc.relation.ispartofConferenceCode |
|
dc.relation.ispartofConferenceDate |
|
dc.relation.ispartofConferenceHosting |
|
dc.relation.ispartofConferenceLoc |
|
dc.relation.ispartofConferenceSponsor |
|
dc.relation.ispartofConferenceTitle |
|
dc.relation.ispartofFundingAgency |
|
dc.relation.ispartOfISOAbbr |
Genet. Test. Mol. Biomark. |
dc.relation.ispartOfIssue |
5 |
dc.relation.ispartOfPart |
|
dc.relation.ispartofPubTitle |
Genetic Testing and Molecular Biomarkers |
dc.relation.ispartofPubTitleAbbr |
Gent. Test. and Mol. Biomarkers |
dc.relation.ispartOfSpecialIssue |
|
dc.relation.ispartOfSuppl |
|
dc.relation.ispartOfVolume |
16 |
dc.source.ID |
WOS:000304448300029 |
dc.type.publication |
Journal |
dc.subject.otherAuthKeyword |
|
dc.subject.otherChemCAS |
5,10 methylenetetrahydrofolate reductase (FADH2), 9028-69-7 |
dc.subject.otherChemCAS |
blood clotting factor 5, 9001-24-5, 9013-23-4 |
dc.subject.otherChemCAS |
prothrombin, 9001-26-7 |
dc.subject.otherChemCAS |
Factor V, 9001-24-5 |
dc.subject.otherChemCAS |
MTHFR protein, human, 1.5.1.20 |
dc.subject.otherChemCAS |
Methylenetetrahydrofolate Reductase (NADPH2), 1.5.1.20 |
dc.subject.otherChemCAS |
Prothrombin, 9001-26-7 |
dc.subject.otherIndex |
5,10 methylenetetrahydrofolate reductase (FADH2) |
dc.subject.otherIndex |
blood clotting factor 5 |
dc.subject.otherIndex |
prothrombin |
dc.subject.otherIndex |
article |
dc.subject.otherIndex |
DNA extraction |
dc.subject.otherIndex |
DNA hybridization |
dc.subject.otherIndex |
emergency care |
dc.subject.otherIndex |
emergency medicine |
dc.subject.otherIndex |
enzyme substrate |
dc.subject.otherIndex |
family medicine |
dc.subject.otherIndex |
gene mutation |
dc.subject.otherIndex |
general surgery |
dc.subject.otherIndex |
genetic association |
dc.subject.otherIndex |
genetic screening |
dc.subject.otherIndex |
genotype |
dc.subject.otherIndex |
human |
dc.subject.otherIndex |
laboratory test |
dc.subject.otherIndex |
mutational analysis |
dc.subject.otherIndex |
patient referral |
dc.subject.otherIndex |
polymerase chain reaction |
dc.subject.otherIndex |
tertiary health care |
dc.subject.otherIndex |
thrombophilia |
dc.subject.otherIndex |
vascular surgery |
dc.subject.otherIndex |
Academic Medical Centers |
dc.subject.otherIndex |
Factor V |
dc.subject.otherIndex |
Female |
dc.subject.otherIndex |
Genetic Testing |
dc.subject.otherIndex |
Genotype |
dc.subject.otherIndex |
Humans |
dc.subject.otherIndex |
Male |
dc.subject.otherIndex |
Medicine |
dc.subject.otherIndex |
Methylenetetrahydrofolate Reductase (NADPH2) |
dc.subject.otherIndex |
Mutation |
dc.subject.otherIndex |
Polymerase Chain Reaction |
dc.subject.otherIndex |
Prothrombin |
dc.subject.otherIndex |
Referral and Consultation |
dc.subject.otherIndex |
Specialties, Surgical |
dc.subject.otherIndex |
Thrombophilia |
dc.subject.otherKeywordPlus |
FACTOR-V-LEIDEN |
dc.subject.otherKeywordPlus |
ADVERSE PREGNANCY OUTCOMES |
dc.subject.otherKeywordPlus |
INHERITED THROMBOPHILIA |
dc.subject.otherKeywordPlus |
VENOUS THROMBOSIS |
dc.subject.otherKeywordPlus |
POPULATION |
dc.subject.otherKeywordPlus |
PREVALENCE |
dc.subject.otherKeywordPlus |
PROTHROMBIN |
dc.subject.otherKeywordPlus |
MUTATIONS |
dc.subject.otherKeywordPlus |
WOMEN |
dc.subject.otherKeywordPlus |
THROMBOEMBOLISM |
dc.subject.otherWOS |
Biochemistry and Molecular Biology |
dc.subject.otherWOS |
Genetics and Heredity |